Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
SelectI am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional
I am a U.S. Patient / CaregiverNo, go back to the patient portal
SelectI am a U.S. Patient / CaregiverNo, go back to the patient portal
Non-US residents click here.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

NURTEC® ODT Medication Guide (rimegepant)

17 PATIENT COUNSELING INFORMATION

Advise patients to read the FDA-approved patient labeling (Patient Information).

Handling of Orally Disintegrating Tablets Packaging

Instruct patients not to remove the blister from the outer aluminum pouch until ready to use the orally disintegrating tablet inside [see Dosage and Administration (2.3)].

Hypersensitivity Reactions

Inform patients about the signs and symptoms of hypersensitivity reactions and that these reactions can occur days after administration of NURTEC ODT. Advise patients to contact their healthcare provider immediately if signs or symptoms of hypersensitivity reactions occur [see Warnings and Precautions (5.1)].

Pregnancy Registry

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to NURTEC ODT during pregnancy. Encourage participation and advise patients about how they may enroll in the registry [see Use in Specific Populations (8.1)].

This product’s labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.

For Medical Information about NURTEC ODT, please visit www.pfizermedinfo.com or call 1 800-438-1985.


PATIENT INFORMATION

PATIENT INFORMATION

NURTEC® ODT (NUR-tek)

(rimegepant)

orally disintegrating tablets (ODT), for sublingual or oral use

What is NURTEC ODT?

NURTEC ODT is a prescription medicine used in adults for the:

•
acute treatment of migraine attacks with or without aura
•
preventive treatment of episodic migraine

It is not known if NURTEC ODT is safe and effective in children.

Do not take NURTEC ODT if you are:

•
allergic to rimegepant, NURTEC ODT, or any of the ingredients in NURTEC ODT.

See the end of this leaflet for a complete list of ingredients in NURTEC ODT.

Before you take NURTEC ODT, tell your healthcare provider about all of your medical conditions, including if you:

•
have liver problems.
•
have kidney problems.
•
are pregnant or plan to become pregnant. It is not known if NURTEC ODT will harm your unborn baby. There is a pregnancy exposure registry for women who take NURTEC ODT during pregnancy. The study is named MONITOR (Migraine Observational NURTEC Pregnancy Registry). A registry is a study. The purpose of this registry is to collect information about your health and the health of your baby. Your healthcare provider can help you enroll in this registry. You may also enroll yourself or get more information about the registry by calling 1-877-366-0324, emailing [email protected], or by visiting nurtecpregnancyregistry.com.
•
are breastfeeding or plan to breastfeed. Very small amounts of NURTEC ODT pass into your breast milk. Talk with your healthcare provider about the best way to feed your baby if you take NURTEC ODT.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take NURTEC ODT?

•
Take NURTEC ODT exactly how your healthcare provider tells you to.
•
For the acute treatment of migraine attacks when they occur, NURTEC ODT can be taken 1 time each day as needed. You should not take more than 1 tablet in 24 hours.
o
It is not known if it is safe to take more than 18 doses of NURTEC ODT in 30 days.
•
For the preventive treatment of episodic migraine, take NURTEC ODT 1 time every other day.
•
To take NURTEC ODT:
o
Use dry hands when opening the blister pack.
o
Peel back the foil covering of one blister and gently remove NURTEC ODT. Do not push NURTEC ODT through the foil.
o
As soon as the blister is opened, remove NURTEC ODT and place on or under the tongue.
o
NURTEC ODT will dissolve and no drink or water is needed.
o
Take NURTEC ODT immediately after opening the blister pack. Do not store NURTEC ODT outside the blister pack for future use.
•
If you take too much NURTEC ODT, go to the nearest emergency room right away.

What are the possible side effects of NURTEC ODT?

NURTEC ODT may cause serious side effects including:

•
Allergic reactions. Allergic reactions, including trouble breathing and rash, can happen after you take NURTEC ODT. This can happen days after you take NURTEC ODT. Call your healthcare provider or get emergency help right away if you have any of the following symptoms, which may be part of an allergic reaction:
o
Swelling of the face, mouth, tongue, or throat
o
Trouble breathing

The most common side effect of NURTEC ODT in acute treatment of migraine attacks with or without aura is:

•
nausea

The most common side effects of NURTEC ODT in preventive treatment of episodic migraine are:

•
nausea
•
stomach pain
•
indigestion

These are not the only possible side effects of NURTEC ODT.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800 FDA-1088.

How should I store NURTEC ODT?

•
Store NURTEC ODT in the blister package that it comes in.
•
Store NURTEC ODT at room temperature between 68°F to 77°F (20°C to 25°C).

Keep NURTEC ODT and all medicines out of the reach of children.

General information about the safe and effective use of NURTEC ODT:

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use NURTEC ODT for a condition for which it was not prescribed. Do not give NURTEC ODT to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about NURTEC ODT that is written for health professionals.

What are the ingredients in NURTEC ODT?

Active ingredient in NURTEC ODT: rimegepant

Inactive ingredients in NURTEC ODT: benzyl alcohol, eucalyptol, gelatin, limonene, mannitol, menthol, menthone, menthyl acetate, sucralose, and vanillin

Pfizer Logo

For more information, go to www.nurtec.com or call 1-833-4NURTEC.

LAB-1548-1.0

This Patient Information has been approved by the U.S. Food and Drug Administration Revised: 2/2023

Show All Hide All
Show All Hide All
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.